BYME
LIVE

Serial Number

79261911

Owner

Owen Mumford Limited

Attorney

Amy C. Ziegler

Filing Date

Feb 18, 2019

Add to watchlist:

No watchlists yet
View on USPTO

BYME Trademark

Serial Number: 79261911 • Registration: 6092992

BYME is a trademark filed by Owen Mumford Limited on February 18, 2019. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Owen Mumford Limited (64 trademarks)

Woodstock, Oxfordshire OX201TU , GB

Entity Type: 03

Trademark Details

Filing Date

February 18, 2019

Registration Date

July 7, 2020

Published for Opposition

April 21, 2020

Goods & Services

sexual activity apparatus, devices and articles, namely, condoms for medical purposes; vaginal dilators for women, vacuum therapy devices; surgical, medical, dental and veterinary apparatus and instruments, namely, for blood sampling, lancets for blood sampling; artificial limbs, eyes and teeth; orthopedic articles, namely, orthopedic belts, orthopedic cast padding, orthopedic footwear, orthopedic hip prostheses, orthopedic inserts for footwear; suture materials; syringes for medical purposes, namely, safety syringes; lancets; medical lancing devices; medical lancing devices, namely, single use lancing devices; blood lancets; disposable lancets for finger puncture; blood testing apparatus; diagnostic apparatus for medical purposes, namely, diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing, medical diagnostic apparatus for testing for HIV, namely, HIV testing kits comprised of lancets, blood collection needles, and test strips; needles for medical purposes; needles for injections, namely, pen needles; needles for injections, namely, safety pen needles; suture needles; hypodermic needles; medical syringes; injection syringes; syringes for medical purposes and for injections, namely, auto-injector medical syringes; syringes for medical purposes and for injections, namely, medical syringe needles; needles for injections; needles for surgical purposes; needles for medical purposes, namely, disposable needles for finger puncture; surgical cutlery; eye droppers; gynecological dilators, namely, vaginal dilators; medical devices for gynecological treatment, namely, gynecological medical instruments for examining women's reproductive organs; medical devices for treating erectile dysfunction, namely, pumps for medical purposes, constriction rings for use in maintaining penile rigidity in men with erectile dysfunction; blood testing equipment, namely, blood collecting tubes, medical equipment for sampling and analyzing blood and body tissue; medical devices for diabetes care, eye care, sexual health, blood sampling, injection, neuropathy, rapid diagnostic testing, point of care testing; tools for medical diagnostics, namely, blood sampling lancets; testing probes for medical purposes; medical instruments for application on human bodies, namely, blood sampling lancets; medical testing instruments, namely, apparatus for medical diagnostic testing in the field of diabetes, sexual health care, blood sampling; diagnostic apparatus for pregnancy testing, namely, ultrasound diagnostic apparatus; medical instruments for testing HIV, namely, blood testing apparatus; testing instruments for medical diagnostic purposes, namely, lancets for blood sampling; urine testing instruments for medical diagnostic purposes, namely, medical specimen collection devices in the nature of cups for the collection of urine; diagnostic testing apparatus for use in immunoassay procedures being medical, namely, apparatus used in implementing diagnosis tests designed to detect infectious diseases; apparatus for DNA and RNA testing for medical purposes; blood pressure testing apparatus, namely, blood pressure monitors; medical instruments, namely, biosensors for detecting infectious diseases; diagnostic, examination, and monitoring equipment for medical purposes, namely, medical examination gloves, blood sampling materials, disposable lancets for finger puncture, blood testing apparatus, namely, test strips and test tubes for measuring blood glucose levels; diagnostic measuring apparatus for medical use; electric instruments for medical use in the diagnosis of blood; genetic testing apparatus for medical purposes; medical specimen collection devices in the nature of glasses for the collection of urine; replacement parts and fittings for all the aforesaid goods

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
May 14, 2026 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 2, 2026 ADCH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 7, 2025 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 24, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 24, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 24, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 24, 2024 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 21, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 2, 2020 FICS
FINAL DISPOSITION PROCESSED
Nov 2, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 7, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 7, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Apr 21, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 19, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 20, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 20, 2020 CRFA
ASSIGNED TO LIE
Feb 20, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 14, 2020 TROA
REFUSAL PROCESSED BY IB
Aug 30, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 15, 2019 RFCS
REFUSAL PROCESSED BY MPU
Aug 15, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 30, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jul 29, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 23, 2019 MAFR
ASSIGNED TO EXAMINER
Jul 19, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 19, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 15, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 4, 2019 REPR